Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge. All articles and interviews are informational only and should never be considered medical advice and should never be acted on without review with your health care team.

It’s Not Over Yet: The Ongoing Impact of COVID-19 for Those with CLL / SLL

Recorded Wednesday, August 24, 2022


As much of the world has seemingly moved on from COVID-19 despite the ongoing global health emergency, the virus continues to pose serious risks for those who are immunocompromised. However, as more options for protection and treatment are being developed, we remain hopeful for the future! Infectious disease specialist, Dr. Shmuel Shoham, will briefly present some of the newest clinical updates and guidance, with the remainder of the event being dedicated to answering audience questions about COVID-19 and CLL / SLL.


Brian Koffman, MDCM (retired), DCFP, FCFP, DABFP, MSEd
Executive Vice President and Chief Medical Officer
CLL Society


Shmuel Shoham, MD
Professor of Clinical Medicine
Johns Hopkins University School of Medicine


Robyn Brumble, MSN, RN
Director of Scientific Affairs and Research
CLL Society

This program was made possible by grant support from AstraZeneca, BeiGene, Bristol Myers Squibb, Pharmacyclics, and Janssen.